Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 6 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 6

From: Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome

Fig. 6

A 56-year-old male patient presented with recently diagnosed pulmonary mass lesion which was pathologically proven bronchogenic carcinoma (grade 4). A large hypermetabolic left upper lobe pulmonary mass is noted extending from lateral pleural surface laterally and merging medially with enlarged left hilar and mediastinal lymph nodes. The SUVmax was 15, MTV was 47.4 ml and the TLG reaching 650 ml. The MIP images and the other images show multiple hypermetabolic metastatic nodal, left pleural, cerebral, splenic, osseous, right adrenal, peritoneal and subcutaneous nodules (the top images; A–D). The corresponding CT images (the bottom images; G–I) showed cerebral ring enhancing deposit, the pulmonary neoplastic mass and the paravertebral metastatic deposit. D Sagittal fused PET/CT image showing bony metastasis affecting L4 vertebra and sacrum. E, F Axial fused PET/CT images showing right adrenal and splenic deposits respectively. G Axial brain CT, H Axial fused PET/CT showing hypermetabolic cerebral ring enhancing deposits. I Axial fused PET/CT image showing hypermetabolic peritoneal and subcutaneous nodules

Back to article page